# The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia

> **NCT01339858** · PHASE4 · COMPLETED · sponsor: **Indiana University** · enrollment: 60 (actual)

## Conditions studied

- Schizophrenia
- Psychotic Disorder NOS
- Schizoaffective Disorder
- Schizophreniform

## Interventions

- **DRUG:** N-Acetyl Cysteine
- **OTHER:** sugar pill

## Key facts

- **NCT ID:** NCT01339858
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01339858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01339858, "The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01339858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
